These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 29613874)

  • 1. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Incidental Findings in the National Lung Screening Trial.
    Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
    JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
    Kowada A
    BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.
    Rai A; Doria-Rose VP; Silvestri GA; Yabroff KR
    J Natl Cancer Inst; 2019 Apr; 111(4):342-349. PubMed ID: 30698792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
    Goulart BH; Bensink ME; Mummy DG; Ramsey SD
    J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.
    Gareen IF; Duan F; Greco EM; Snyder BS; Boiselle PM; Park ER; Fryback D; Gatsonis C
    Cancer; 2014 Nov; 120(21):3401-9. PubMed ID: 25065710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening.
    Morgan L; Choi H; Reid M; Khawaja A; Mazzone PJ
    Ann Am Thorac Soc; 2017 Sep; 14(9):1450-1456. PubMed ID: 28421812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearing the air: steps for lung cancer screening success.
    Jokerst C; Oliva I; Mohammed TL
    Curr Probl Diagn Radiol; 2015; 44(2):113-7. PubMed ID: 25541106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.
    Gohagan J; Marcus P; Fagerstrom R; Pinsky P; Kramer B; Prorok P;
    Chest; 2004 Jul; 126(1):114-21. PubMed ID: 15249451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.
    Gohagan JK; Marcus PM; Fagerstrom RM; Pinsky PF; Kramer BS; Prorok PC; Ascher S; Bailey W; Brewer B; Church T; Engelhard D; Ford M; Fouad M; Freedman M; Gelmann E; Gierada D; Hocking W; Inampudi S; Irons B; Johnson CC; Jones A; Kucera G; Kvale P; Lappe K; Manor W; Moore A; Nath H; Neff S; Oken M; Plunkett M; Price H; Reding D; Riley T; Schwartz M; Spizarny D; Yoffie R; Zylak C;
    Lung Cancer; 2005 Jan; 47(1):9-15. PubMed ID: 15603850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose computed tomography screening for lung cancer: results of the first screening round.
    Horeweg N; Nackaerts K; Oudkerk M; de Koning HJ
    J Comp Eff Res; 2013 Sep; 2(5):433-6. PubMed ID: 24236740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.